MYD88 and acute myeloid leukemia: In the mouse model of acute myeloid leukemia (AML), IFN-γ receptor 1 (IFNGR1) suppression can decrease the expression of PD-L1 through the MEK/ERK and MYD88/TRAF6 pathways [79].